MARKET

TTOO

TTOO

T2 Biosystems
NASDAQ
1.660
+0.010
+0.61%
Opening 11:33 11/29 EST
OPEN
1.630
PREV CLOSE
1.650
HIGH
1.700
LOW
1.630
VOLUME
63.09K
TURNOVER
88.83K
52 WEEK HIGH
34.00
52 WEEK LOW
1.555
MARKET CAP
12.15M
P/E (TTM)
-0.1003
1D
5D
1M
3M
1Y
5Y
T2 Biosystems Third Quarter 2022 Earnings: Misses Expectations
T2 Biosystems ( NASDAQ:TTOO ) Third Quarter 2022 Results Key Financial Results Revenue: US$3.68m (down 51% from 3Q...
Simply Wall St. · 11/16 10:08
Why Infinity Pharmaceuticals Shares Tumbled Around 38%; Here Are 79 Biggest Movers From Yesterday
Benzinga · 11/15 10:19
BRIEF-T2 Biosystems Announces Amendment, Extension Of CRG Term Loan Agreement
Reuters · 11/10 22:59
BRIEF-T2 Biosystems Announces Third Quarter 2022 Financial Results
Reuters · 11/10 21:35
T2 Biosystems Sees FY22 Revenue $22M-$23M Vs $26.33M Est.
Benzinga · 11/10 21:20
T2 Biosystems Q3 Sales $3.68M Miss $5.90M Estimate
Benzinga · 11/10 21:19
T2 Biosystems GAAP EPS of -$2.95 misses by $0.90, revenue of $3.68M misses by $1.05M
Seekingalpha · 11/10 21:10
-- Earnings Flash (TTOO) T2 BIOSYSTEMS Reports Q3 Loss $-2.95, vs. Street Est of $-2.05
-- Earnings Flash (TTOO) T2 BIOSYSTEMS Reports Q3 Loss $-2.95, vs. Street Est of $-2.05
MT Newswires · 11/10 16:26
More
About TTOO
T2 Biosystems, Inc. is an in-vitro diagnostics company. The Company is focused on rapid detection of sepsis-causing pathogens and antibiotic resistance genes. The Company is using its T2MR technology, which enables rapid detection of pathogens, biomarkers and other abnormalities in a variety of unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum and urine, and can detect cellular targets at limits of detection as low as one colony forming unit per milliliter (CFU/mL). Its products include the T2Dx Instrument, T2Candida Panel, the T2Bacteria Panel, the T2Resistance Panel, and the T2SARS-CoV-2 Panel that are all powered by the T2MR technology. Its T2Candida Panel is a direct-from-blood test that identifies the lethal form of common blood stream infections that cause sepsis and candidemia. Its T2Bacteria Panel is a direct-from-blood test that detects certain bacterial pathogens associated with sepsis.

Webull offers kinds of T2 Biosystems Inc stock information, including NASDAQ:TTOO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TTOO stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading TTOO stock methods without spending real money on the virtual paper trading platform.